While previous research has reported GCKR as a disease-predisposing variant for NAFLD [16], this study found an association between GCKR and a decreased risk of MASLD (OR = 0.938 [95% CI 0.927–0.949]. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.